term male infant born to 38 years old G3P1 +2 female via Cesarean section due to breech presentation. In current pregnancy she has additional risk factors of gestation diabetes, advanced maternal age and polyhydromnios on antenatal ultrasounds.
Infant was admitted to Neonatal Unit on day one due to dysmorphic facial features and poor feeding. Serum electrolytes were checked at 24 hours of life and showed serum sodium of 143 mmol/L, BUN of 3.6 mmol/L, and creatinine of 68 umol/L. Serum sodium raised to 148 mmol/L at 48 hours and 155 mmol/L at 72 hours of life. So suspicion of diabetes insipidus (DI) was raised. On day three, it was also noted that serum glucose (2.7mmol/L [3.9-7.8]), serum osmolality: 320mOsm/kg [282-300], urine specific gravity: 1.005, urine osmolality of 105 mOsm/kg and urine sodium of 86mmol/L.
On subsequent days further radiological investigations were conducted. Renal ultrasound was reported as normal. Cranial Ultrasound showed enlarged lateral ventricles, measuring 5.2 mm x 3.3 mm.
Computed Tomography (CT) Brain: prominent lateral ventricles, mild trans ependymal edema, normal 3 rd and 4 th ventricles, otherwise normal findings.
We determined that the cause of the patient's hypernatremia was likely secondary to DI. Endocrine team was contacted and conducted DDAVP [a One dose of subcutaneous (SC) desmopressin, (DDAVP 100 ng) corrected his urine specific gravity, serum sodium, and serum osmolality to within normal range.
Thus, we concluded that his ADH receptors at the level of the nephron were functioning properly, and his DI was central in etiology. The infant would require synthetic ADH for the rest of his life.
So, on day five (DDAV received on day 4); Serum sodium 136 mmol/L, serum osmolality: 298 mmol/kg, urine osmolality: 493 mOsm/kg, urine sodium: 35 mmol/L, FSH: <0.5 (0.8-9.0) and LH: <0.5 (0.8-7.6) (Figure 1) .
The low levels of other pituitary hormones leads us to believe the infant has perhaps an underlying pan-hypo-pituitarism.
Results of karyotyping from day one showed a translocation of chromosomes 9p and 18q.
This chromosomal abnormality has never been documanted before.
Since chromosome 9 is half of 18, it is possible that this is an imbalance of chromosomes rather than a true translocation. 
PHENOTYPIC PERTINENT PHYSICAL EXAM FINDING

DISCUSSION
Diabetes derived from a Greek word "diabainein" meaning Siphon-to pass through; referring to excessive urination associated with the disease.
Insipidus derived from the Latin word meaning "without taste," DI involves the passing of tasteless urine due to low sodium content.
Mellitus is also a Latin word meaning "sweet." Due to the excessive sugar found in blood and urine of a diabetic patient. 1 DI is a life threatening condition, as it causes fluid and electrolyte imbalance that results in polyuria, weight loss, diluted urine, severe hypernatremic dehydration. 2 There are a variety of pathologic processes can impede the production or secretion of adrenal diuretic hormone (ADH) and leads to Central DI, which includes idiopathic, infectious, trauma, malignancy, genetic, familial, intracranial haemorrhage and hypoxia. Synthetic ADH analogue, DDAVP is the main stay of treatment in central DI. It is available in intranasal, oral, SC, and intravenous preparation.
Polyuria in central DI could also be control with a paradoxical antidiuretic effect of thiazide diuretics. 4, 5 Genetic counselling is necessary, because the recurrence risk significantly increases if one of the parents is a carrier. Antenatal diagnosis is possible by conducting amniocentesis, chorionic villus sampling and cytogenetic testing including FISH. The details about this rare genetic condition could be taken from the "Unique understanding of chromosomal disorders" website for support and information. 6, 7 http://www. rarechromo.org/html/Disorder Guides.asp and NORD (National Organisation for Rare Disorders) 18-monosomy-18p/.
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